Comprehensive panel based approach to clinical genetics, with over 200 panels covering 14 medically relevant specialties

February 23, 2017

We are on a mission to challenge the standards of clinical genetic diagnostics to enable better patient care. Over the last 5 years we have developed unique sequencing technologies, in-house bioinformatics and interpretation solutions to improve rare disease genetic diagnostics. Without compromising quality and performance, our innovations are enabling more affordable…
Blueprint Genetics listed as one of the hottest start-up companies in Finland!

February 21, 2017

The Jury of Talouslämä, a Finnish weekly business magazine listed the top ten hottest start-up companies in Finland. The selection was made among hundreds of companies. We are delighted to be on the list for the third year in a row!   Read the whole article:   Talouselämä 6/2017, published…
Blueprint Genetics on Kauppalehti Optio – an article about the life science and health technology innovations in Finland

November 24, 2016

Article about the life science and health technology innovations and the growth of the healthcare industry in Finland on Kauppalehti Optio, a Finnish business magazine. To read the whole article (available in Finnish only), click here.   Blueprint Genetics yhdessä muiden life science ja terveysalanyritysten kanssa viemässä huipputason terveysteknologiaa…
Blueprint Genetics becomes the first laboratory to receive ISO 15189 accreditation for a NGS pipeline from sample arrival to clinical interpretation

February 02, 2016

Blueprint Genetics is now an ISO 15189 standard accredited No. T292 laboratory. Accreditation is a procedure to recognize an organization’s competence to carry out specific tasks based on internationally agreed criteria. The quality management system at Blueprint Genetics complies with the international ISO 15189 standard, which specifies the quality requirements for medical…

Media kit

Subscribe to our press releases